Although no correlation was observed between more aggressive tumor stages and hnRNPA2B1 expression (Fig. 2c), GC patients with high hnRNPA2B1 expression displayed more adverse overall survival by Kaplan–Meier survival analysis (p < 0.001, Fig. 2d). The gene discussed is HNRNPA2B1; the disease is neoplasm.